The whole-cell vaccine for liver cancer targeting STAT3 reversed the depletion of T cells and NK cells in the liver cancer microenvironment, which may be attributed to the low expression of PD-1 and TIGIT (81). The gene discussed is TIGIT; the disease is liver cancer.